Key facts for J7502
- Billing unit
- 100 MG
- Cyclosporine oral 100 mg
- ASP payment limit
- $1.455
- October 2026; -6.7% vs July 2026
- Practitioner MUE
- 0
- MAI 3
- OPPS status
- SI N
- NCCI exposure
- no PTP pairs
- Coverage articles
- 0
- none list this code
TL;DR
HCPCS J7502 is the Level II code for Cyclosporine, oral, 100 mg, billed per 100 MG. The Medicare Part B ASP payment limit for October 2026 is $1.455 per billing unit, down 6.7% from July 2026. The practitioner MUE allows up to 0 units per date of service (MAI 3). Under OPPS it carries status indicator N. Oral drugs under Part B are payable only in the specific statutory categories (for example oral anticancer or antiemetic drugs with a self-administration exception), so the diagnosis and the regimen must match that category. Other HCPCS codes whose descriptor names cyclosporine: J7515 (billed per 25 mg); J7516 (billed per 250 mg). The ASP crosswalk maps 14 NDCs to it, sold as Gengraf, Sandimmune, Neoral by AbbVie Inc., Novartis Pharmaceuticals Corporation, Teva Pharmaceuticals USA, Inc. No current Billing and Coding Article lists J7502, so coverage follows the FDA label, compendia and any applicable NCD.
Medicare Part B payment limit (ASP)
CMS sets the Part B payment limit for J7502 at $1.455 per 100 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $1.559 in July 2026. Beneficiary coinsurance is 20%.
| Quarter | Payment limit | Per | Coinsurance |
|---|---|---|---|
| October 2026 | $1.455 | 100 MG | 20% |
| July 2026 | $1.559 | 100 MG | — |
NDC to HCPCS billing-unit conversion
The October 2026 ASP crosswalk maps 14 NDCs from 7 labelers to J7502. Report the NDC in the claim's drug segment and bill the number of J7502 units that equals the quantity administered divided by 100 MG; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 00074-3109-32 | Gengraf | AbbVie Inc. | 30 × 1 | 30 |
| 00074-7269-50 | Gengraf | AbbVie Inc. | 50 × 1 | 50 |
| 00078-0110-22 | Sandimmune | Novartis Pharmaceuticals Corporation | 50 × 1 | 50 |
| 00078-0241-15 | Sandimmune | Novartis Pharmaceuticals Corporation | 30 × 1 | 30 |
| 00078-0248-15 | Neoral | Novartis Pharmaceuticals Corporation | 30 × 1 | 30 |
| 00078-0274-22 | Neoral | Novartis Pharmaceuticals Corporation | 50 × 1 | 50 |
| 00093-9018-65 | Cyclosporine | Teva Pharmaceuticals USA, Inc. | 30 × 1 | 8 |
| 00093-9019-65 | Cyclosporine | Teva Pharmaceuticals USA, Inc. | 30 × 1 | 15 |
| 00093-9020-65 | Cyclosporine | Teva Pharmaceuticals USA, Inc. | 30 × 1 | 30 |
| 00172-7313-20 | Cyclosporine | Ivax Pharmaceuticals, Inc. | 50 × 1 | 50 |
| 23155-0839-30 | Cyclosporine | Heritage Pharmaceuticals Inc. | 30 × 1 | 30 |
| 60505-0134-00 | Cyclosporine | Apotex Corp | 30 × 1 | 30 |
| 60505-4632-03 | Cyclosporine | Apotex Corp | 30 × 1 | 30 |
| 68084-0921-25 | Cyclosporine | American Health Packaging | 30 × 1 | 30 |
Medically Unlikely Edits (MUE)
CMS publishes 3 MUE values for J7502. For practitioners the limit is 0 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.
| Setting | MUE (units/DOS) | MAI | CMS rationale |
|---|---|---|---|
| Practitioner services | 0 | 3 Date of Service Edit: Clinical | Oral Medication; Not Payable |
| Facility outpatient hospital | 60 | 3 Date of Service Edit: Clinical | Clinical: Data |
| DME supplier | 720 | 3 Date of Service Edit: Clinical | CMS Policy |
MUE for J7502 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
Medicaid NCCI differs: the 2026 Q4 Medicaid MUE for J7502 is 60 units for practitioner claims (Medicare: 0) and 240 units for DME supplier claims (Medicare: 720). Compare both programs in the MUE lookup or read how Medicaid NCCI differs from Medicare.
NCCI edits and add-on relationships
No active practitioner PTP pair lists J7502 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check J7502 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
J7502 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
No current Billing and Coding Article lists J7502 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.
Local coverage policies that list J7502
1 active Local Coverage Determination lists J7502 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.
- LCD L33824: Immunosuppressive Drugs · CGS Administrators, LLC; Noridian Healthcare Solutions, LLC
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, J7502 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), J7502 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.
Common denials for J7502 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for J7502
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS J7502
What does HCPCS code J7502 describe?
J7502 is defined by CMS as "Cyclosporine, oral, 100 mg". Each billing unit represents 100 MG, so the units reported on the claim must equal the dose administered divided by that unit.
Is J7502 a CPT code?
No. J7502 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as cyclosporine; CPT codes are five-character codes maintained by the AMA. On a Part B claim J7502 reports the drug itself in 100 mg units, and the administration is billed on its own line.
What is the Medicare reimbursement for J7502 in October 2026?
The ASP-based payment limit is $1.455 per 100 MG, with 20% beneficiary coinsurance. The July 2026 limit was $1.559. Commercial payers use their own fee schedules.
How many units of J7502 can be billed per day?
The practitioner Medically Unlikely Edit is 0 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 60. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Oral Medication; Not Payable" as the rationale.
Which NDCs map to J7502?
The October 2026 ASP crosswalk lists 14 NDCs from 7 labelers: Gengraf (AbbVie Inc.); Sandimmune (Novartis Pharmaceuticals Corporation); Neoral (Novartis Pharmaceuticals Corporation); Cyclosporine (Teva Pharmaceuticals USA, Inc.). For example NDC 00074-3109-32 (package size 30) equals 30 billing units of J7502.
Does J7502 have NCCI bundling edits?
No active practitioner PTP pairs list J7502 as a column-1 or column-2 code in the v323r0 release.
J7502 vs J7515: what is the difference?
Both are HCPCS Level II codes whose descriptor names cyclosporine. What sets J7515 apart: billed per 25 mg. J7502 is billed per 100 mg, limit $1.455, MUE 0; J7515 is billed per 25 mg, limit $0.576, MUE 0. Report the code whose descriptor matches the product and setting in the record.
J7502 vs J7516: what is the difference?
Both are HCPCS Level II codes whose descriptor names cyclosporine. What sets J7516 apart: billed per 250 mg. J7502 is billed per 100 mg, limit $1.455, MUE 0; J7516 is billed per 250 mg, limit $75.649, MUE 1. Report the code whose descriptor matches the product and setting in the record.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- Medicare Part B Drug Payment Limit File, July 2026Version July 2026 · effective 2026-07-01 · file section 508 version of July 2026 Medicare Part B Payment Limit File updated 082026.csvSHA-256 13bb5b644b92b574…
- ASP NDC-HCPCS Crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 ASP NDC-HCPCS Crosswalk 091126.csvSHA-256 5cb78f0c2ee786ba…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.